Please note: AABB reserves the right to make further updates to this program.
Tuesday, June 18, 2019
2:00 – 3:00 PM (ET) 7:00 – 8:00 PM (GMT)
Master Program Number: 19EL-446 (see program format numbers below under Registration)
Educational Track: Scientific
Topic: Transfusion Medicine
Intended Audience: Research Scientists, Resident/Fellow, Scientists, Students (MD, MT, SBB), Early-stage investigators*
Teaching Level: Basic
Director/Panel Member: Amy Quiggins, MFA, Director, National Blood Foundation, AABB, Bethesda, MD
Moderator: James D. Gorham, MD, PhD, Chief, Division of Laboratory Medicine, Medical Director, Blood Bank and Transfusion Medicine Services, Professor, Department of Pathology, University of Virginia Health System, Charlottesville, VA
Speakers: James D. Gorham, MD, PhD, Chief, Division of Laboratory Medicine, Medical Director, Blood Bank and Transfusion Medicine Services, Professor, Department of Pathology, University of Virginia Health System, Charlottesville, VA; Christopher A. Tormey, MD, Associate Professor of Laboratory Medicine, Director, Transfusion Medicine Fellowship, Yale University School of Medicine, New Haven, CT; Avital Mendelson, PhD, Assistant Member, Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY
After participating in this educational activity, participants should be able to:
- Define NBF’s initiative to advance transfusion medicine and cellular therapies by funding innovative scientific research.
- Prepare necessary materials for the 2020 early-career Scientific Research Grants cycle.
- Describe what goes into producing a competitive early-stage grant application.
Early-stage investigators often struggle to attain seed funding to gain the necessary data for larger research grants that will support an independent research career. This type of early-stage funding can profoundly impact the career trajectory of someone starting out in transfusion medicine. This program aims to provide information about AABB’s National Blood Foundation (NBF) and its initiative to support early-stage investigators at a critical time in their careers. Hear from the 2020 Scientific Research Grants Review Committee Chair to learn about the early-career grant program and important dates for applying in the 2020 grant cycle. A prior NBF grant recipient, who also serves on the application review panel, will describe the scoring system used and provide key insights into what grant reviewers look for in the applications. Program participants will also gain some perspective on how to develop a strong grant application. Finally, a recent NBF grant recipient will describe the resubmission process and value gained by experiencing the educational component to NBF’s early-career grant program and reviewer critiques.
For the 2020 grant cycle, the NBF will accept grant applications from July 1 – December 1, 2019. Eligible AABB members can submit grant applications without a fee. For participating in this eCast, non-AABB members will receive a promocode for 25% off the 2020 grant application fee. This promocode will be provided via email to participants by July 1.
| || ||
|Single Viewer: Live||
|Single Viewer: On-Demand||
|Group Viewing: Live||
|Group Viewing: On-Demand||
|Group Viewing: Live & On-Demand||
Continuing Education Credit
AABB estimates both the live and on-demand version of this eCast each to be eligible for 1 continuing education credits/contact hours for Physicians, California Nurse, California Lab Personnel, Florida Lab Personnel and General Participation credit. The final number of credit(s) and credit types awarded for this program (live or on-demand) will be determined by the program duration. For more information on each credit type please visit our
Continuing Education Credits webpage.
* The NBF describes an early-stage investigator as a new investigator who has completed a terminal research degree or medical residency – whichever date is later – within 10 years of the grant application deadline and has not yet been awarded a substantial research grant (i.e. NIH R01). Of note, there is a 13-month period during which an investigator can resubmit a revised application and retain early-stage investigator status. Clinical fellowship training in a medical specialty or subspecialty training in the years that follow the internship/residency period is not considered a part of the residency. Often the clinical fellowship period will consist of a mixture of clinical and research training. The time spent in research training will be considered as applicable toward the 10 years of research and research training.